HIRAWAT SAMIT 1781290 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-07-01 | 2023-07-01 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | acq | 9357.0 | 17.98 | 0.04 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 52032.0 | 2100.85 (BMY) |
| 2023-07-05 | 2023-07-01 | 2023-07-01 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | dsp | 4787.0 | 9.2 | 0.02 | 63.95 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F | 47245.0 | 2100.85 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | dsp | 25354.0 | 29.61 | 0.13 | 28.96 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 60279.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | acq | 38388.0 | 47.83 | 0.19 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 80256.0
|
2022.19 (BMY) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-07-01 | 2023-07-01 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | dsp | 9357.0 | 100.0 | 0.04 | 0.0 | Direct | Restricted Stock Units | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2100.85 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | acq | 40635.0 | 100.0 | 0.2 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 40635.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | dsp | 19696.0 | 52.86 | 0.1 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 17565.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | acq | 60952.0 | 100.0 | 0.3 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 60952.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hirawat Samit | EVP,CHIEF MED.OFFR.,DRUG DEV. | dsp | 29311.0 | 100.0 | 0.14 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)